StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$25.13+0.92 (+3.80%)

Close on Nov 18, 2026Market cap $691.46MP/E –Yield –

Fulgent Genetics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Fulgent Genetics's pe ratio was 6.5× on Apr 28, 2023, against 3.3× a year earlier. Over the last 3 years it ranged from 3.0× to 333.7×, with a median of 5.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Apr 28, 20236.5×+3.0
2022Dec 30, 20223.4×−1.8
2021Dec 31, 20215.2×−20.6
2020Dec 31, 202025.8×–

More Fulgent Genetics figures

See a number that looks wrong?